Prenetics Global PRE 深 滬
等待開盤 09-24 09:30:00 美东时间
22.71
-0.190
-0.83%
華盛通- 最 高23.545
- 今 開22.95
- 成交量 24.58万股
- 最 低 22.35
- 昨 收 22.90
- 總市值 3.89亿
- 52周最高 27.24
- 市盈率 靜 --
- 換手率 1.43%
- 52周最低 11.365
- 委 比 99.90%
- 總股本 1714.35万
- 歷史最高 131.25
- 量 比 1.22
- 振 幅 5.22%
- 歷史最低 2.85
- 每 手 1
- 風險率 3.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 赛富时获多家机构上调目标价，最高至300美元！谷歌获看多至450美元，仍有3成上涨空间
今日重点评级关注：Canaccord Genuity：维持Generac Holdings"买入"评级，目标价从275美元升至375美元；巴克莱：维持Oscar Health"超配"评级，目标价从39美元升至49美元
09-18 16:18
Craig-Hallum Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $40
Craig-Hallum analyst Eric Des Lauriers initiates coverage on Prenetics Global (NASDAQ:PRE) with a Buy rating and announces Price Target of $40.
09-17 22:36
美股大行评级 | 潜在涨幅1024.26%！Ascendiant Capital上调PAVmed目标价至57美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从56美元升至57美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9.25美元升至9.5美元
08-28 16:15
美股牛股 | 业绩股获资金追捧！爱芬奇飙升35.7%，BOSS直聘升近16%；Biohaven劲升17.9%，斩获近8亿美元许可协议
亮眼财报成“吸金石”！爱芬奇绩后飙升35.7%，全年EPS指引上调至最高13.6美元；BOSS直聘升近16%，宣布2.3亿美元派息计划；Biohaven劲升17.9%，获7.95亿美元许可协议。
08-27 15:41
Prenetics Global CEO and CFO purchase $1M of shares in open market
Prenetics Global (PRE) announced on Wednesday that Danny Yeung, chief executive officer, and Brian Rosin, chief financial officer, completed open market purchases of its ordinary shares during the pe...
08-26 20:57
Prenetics Global Sees FY2026 Sales $220.000M-$230.000M vs $214.071M Est
Prenetics Global (NASDAQ:PRE) sees FY2026 sales of $220.000 million-$230.000 million vs $214.071 million analyst estimate.
08-18 19:40
Prenetics Global Sees Q3 Sales $63.000M-$64.000M vs $59.310M Est
Prenetics Global (NASDAQ:PRE) sees Q3 sales of $63.000 million-$64.000 million vs $59.310 million analyst estimate.
08-18 19:40
Prenetics Global Initiates FY2027 guidance of $400 million+ in IM8 revenue
Prenetics Global (NASDAQ:PRE) initiates FY2027 guidance of $400 million+ in IM8 revenue.
08-18 19:35
Prenetics Global Q2 EPS $(0.53) Beats $(0.71) Estimate, Sales $46.488M Miss $48.920M Estimate
Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.71) by 25.35 percent. This is a 35.37 percent increase over losses of $(0.82) per share from the same period last year. The company reported quarterly sales of $46.488 millio...
08-18 19:34
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
Prenetics reported Q2 2026 revenue of $46.5 million, up 288% YoY, with IM8 contributing $45 million, up 359% YoY. July marked IM8's strongest month at $20.9 million, annualizing to $251 million. The company raised FY2026 revenue guidance to $220-$230 million and initiated FY2027 IM8 guidance of $400 million+. CEO Danny Yeung highlighted the sixth consecutive record quarter, positive Adjusted Free Cash Flow, and a new reporting approach with detai...
08-18 11:30
